our team

ManagEment

Andréa C. LeBlanc, PhD

Founder & CEO

Professor & Head of an Alzheimer’s research laboratory, Department of Neurology & Neurosurgery, McGill University (1993-2019)
Internationally recognized for contributions to neurodegeneration research
Pharma Collaborations (Merck, Pfizer, Neurochem)
QcES Entrepreneurship Certificate

Rahul Sarugaser, PhD

Chief Financial & Business Officer

Previously Managing Director & Head of Biotechnology & Healthcare equity research at Raymond James, Canada
Brings two decades of experience in venture capital, capital markets, and biotech financing

Serge Gauthier, MD, FRCPC, CM, CQ

Chief Medical Officer (Consultant)

Emeritus Professor of Neurology & Neurosurgery at McGill University and internationally recognized Alzheimer’s clinician-scientist
Led and contributed to numerous global AD trials and the validation of key cognitive endpoints

Paolo Vitali, MD, PhD, FRCPC

Principal Investigator (Ph2 Clinical Trial)

Associate Professor and Director, Alzheimer Disease Research Unit, Douglas Mental Health Institute, McGill University
Neurologist and neuropsychologist specializing in Alzheimer’s clinical trials, regulatory compliance, and patient-focused design

Advisors

Aaron Davidson

Corporate & Financing Strategy

Didier Leconte

Corporate & Financing Strategy

Michael Heneka, MD

Alzheimer Disease KOL, Clinical Strategy

David Parkinson, MD

Clinical & Corporate Strategy

François Ravenelle, PhD

Clinical & Corporate Strategy

Discover our approach